Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amlodipine/azilsartan/hydrochlorothiazide

Next Previous
Search
Drug Profile

Amlodipine/azilsartan/hydrochlorothiazide

Alternative Names: Amlodipine/hydrochlorothiazide/azilsartan; Azilsartan/amlodipine/hydrochlorothiazide; Azilsartan/hydrochlorothiazide/amlodipine; Hydrochlorothiazide/amlodipine/azilsartan; Hydrochlorothiazide/azilsartan/amlodipine; TAK-536/AML/HCTZ; TAK-536TCH

Latest Information Update: 04 Jul 2017

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Takeda
  • Class Antihypertensives; Benzimidazoles; Benzothiadiazines; Dihydropyridines; Oxadiazoles; Small molecules
  • Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists; Cytochrome P-450 enzyme system inhibitors; Thiazide diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Essential hypertension

Most Recent Events

  • 04 Jul 2017 Chemical structure information added
  • 10 May 2017 Discontinued - Preregistration for Essential hypertension in Japan (PO) based on the outcomes of market research (Takeda FY2016 Q4 results, May 2017)
  • 01 Jun 2016 Takeda completes a phase III trial in Essential hypertension in Japan (NCT02277691; JapicCTI-142689)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top